autoimmune diseases

Showing NaN - NaN of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Scleroderma, Diffuse, Scleroderma, Systemic, Scleroderma, Limited Trial in India, United States (Oral Ifetroban, Oral Placebo)

Recruiting
  • Scleroderma, Diffuse
  • +7 more
  • Oral Ifetroban
  • Oral Placebo
  • Tucson, Arizona
  • +15 more
Jun 30, 2022

PANDAS, Anxiety Disorder, Autoimmune Diseases Trial in Boston (Naproxen Sodium, Placebo)

Recruiting
  • PANDAS
  • +3 more
  • Naproxen Sodium
  • Placebo
  • Boston, Massachusetts
    Massachusetts General Hospital
Feb 14, 2022

Autoimmune Diseases, NSCLC, Rheumatoid Arthritis Trial in United States (Nivolumab)

Unknown status
  • Autoimmune Diseases
  • +9 more
  • Chicago, Illinois
  • +10 more
Jun 14, 2021

Autoimmune Diseases, Systemic Inflammatory Process, Knee Pain Chronic Trial in Boston (drug, dietary supplement, other)

Active, not recruiting
  • Autoimmune Diseases
  • +4 more
  • Fish Oil
  • +2 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Mar 15, 2021

Neurological Disorder, Autoimmune Diseases Trial in Canada, United States (Mycophenolate Mofetil, Azathioprine)

Completed
  • Neurological Disorder
  • Autoimmune Diseases
  • Palo Alto, California
  • +18 more
Feb 2, 2021

Chemical Injuries, Unspecified Complication of Corneal Transplant, Autoimmune Diseases Trial in Boston (Riboflavin)

Completed
  • Chemical Injuries
  • +7 more
  • Boston, Massachusetts
    Massachusetts Eye and Ear Infirmary
Oct 18, 2019

Chronic Kidney Disease, Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) Trial in Boston (Haploidentical Bone

Unknown status
  • Chronic Kidney Disease
  • +16 more
  • Haploidentical Bone Marrow/Kidney
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 21, 2017

Autoimmune Diseases, Multiple Sclerosis Trial in Boston (Glatiramer acetate, Albuterol, Albuterol )

Completed
  • Autoimmune Diseases
  • Multiple Sclerosis
  • Glatiramer acetate
  • +2 more
  • Boston, Massachusetts
    Brigham and Women's Hospital/Harvard Medical School
Sep 20, 2016

Immunologic Diseases, Autoimmune Diseases, Systemic Lupus Erythematosus Trial in Worldwide (Abetimus sodium (LJP 394))

Completed
  • Immunologic Diseases
  • +4 more
  • Abetimus sodium (LJP 394)
  • Birmingham, Alabama
  • +81 more
Sep 22, 2006